Impaired Homocysteine Metabolism Associated with High Plasma Interleukin- 17A Levels, a Pro-Atherogenic Marker, in an Endogamous Population of North India | Zendy

Lovejeet Kaur | Zendy; Priyanka Rani Garg | Zendy; Pradeep Kumar Ghosh | Zendy; Kallur Nava Saraswathy | Zendy

Open Access

Impaired Homocysteine Metabolism Associated with High Plasma Interleukin- 17A Levels, a Pro-Atherogenic Marker, in an Endogamous Population of North India

Author(s) -

Lovejeet Kaur,

Priyanka Rani Garg,

Pradeep Kumar Ghosh,

Kallur Nava Saraswathy

Publication year - 2018

Publication title -

ethnicity and disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.767

H-Index - 67

eISSN - 1945-0826

pISSN - 1049-510X

DOI - 10.18865/ed.28.4.525

Subject(s) - homocysteine , methylenetetrahydrofolate reductase , medicine , hyperhomocysteinemia , peripheral blood mononuclear cell , dyslipidemia , lipid profile , endocrinology , anthropometry , plasma homocysteine , body mass index , population , immunology , biology , obesity , cholesterol , genotype , genetics , environmental health , in vitro , gene

Impaired homocysteine metabolism (IHM; hyperhomocysteinemia) has been linked with many complex disorders like cardiovascular diseases and immunological disturbances. However, studies understanding IHM in light of pro- and anti- atherogeneic markers like Interleukin-17A & -10 (IL-17A & IL-10) and Forkhead box p3 (Foxp3, a master transcription factor) are scarce.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research